Jeffrey Trigilio, Chief Financial Officer at Cullinan Oncology, Inc. (CGEM), sold 1,920 shares at $8.50 ($16K) on 2023-12-21, disclosed to the SEC on 2023-12-22.
Open-market sale of $16k CGEM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CGEM | SELL | 2023-06-21 | $5K | — | Filing → |
| CGEM | SELL | 2023-06-14 | $4K | — | Filing → |
| CGEM | SELL | 2023-05-19 | $3K | — | Filing → |